406 related articles for article (PubMed ID: 11234463)
1. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
[TBL] [Abstract][Full Text] [Related]
3. Aspirin--anticoagulant combination in patients with non valvular atrial fibrillation commentary on the FFAACS study results.
Lechat PP
Card Electrophysiol Rev; 2003 Dec; 7(4):372-3. PubMed ID: 15071257
[TBL] [Abstract][Full Text] [Related]
4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
5. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
7. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
[TBL] [Abstract][Full Text] [Related]
12. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
[TBL] [Abstract][Full Text] [Related]
13. Which parameters differ in very old patients with chronic atrial fibrillation treated by anticoagulant or aspirin? Antithrombotic treatment of atrial fibrillation in the elderly.
Doucet J; Gréboval-Furstenfeld E; Tavildari A; M'bello L; Delaunay O; Pesqué T; Moirot P; Mouton-Schleifer D
Fundam Clin Pharmacol; 2008 Oct; 22(5):569-74. PubMed ID: 18844728
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
[TBL] [Abstract][Full Text] [Related]
16. [Thromboembolic complications of arrhythmia due to atrial fibrillation].
Lekieffre J; Lacroix D; Klug D; Kacet S
Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():17-23. PubMed ID: 7786120
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial.
Pérez-Gómez F; Iriarte JA; Zumalde J; Berjón J; Salvador A; Alegría E; Maluenda MP; Asenjo S; Perez-Saldaña R; de la Torre RG; Bover R; Fernández C
Eur Heart J; 2007 Apr; 28(8):996-1003. PubMed ID: 17158523
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
19. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
[TBL] [Abstract][Full Text] [Related]
20. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
